IB10 sphingotest ® bio-ADM Plus

IB10 sphingotest ® bio-ADM® Plus, is a rapid point-of-care (POC) immunoassay for the in vitro quantitative determination of human amidated adrenomedullin peptide (1-52), in the following referred as bioactive adrenomedullin (bio-ADM®), in human EDTA whole blood and plasma. The IB10 sphingotest® bio-ADM® Plus Test is intended for use in conjunction with the Nexus IB10 Analyzer and provides quantitative results within 20 minutes. The IB10 sphingotest® bio-ADM® Plus measurement is intended to be used in conjunction with clinical assessments and other laboratory findings as an aid in the prediction of the need for vasopressor therapy in patients with sepsis or septic shock. The IB10 sphingotest® bio-ADM® Plus is designed for professional use only and may be used in hospital central laboratories and in alternate care settings such as emergency departments, critical care units, and other sites where near patient testing is practiced.